Tumor necrosis factor alpha 308 G/A polymorphism and hepatocellular carcinoma risk in a Chinese population

Genet Test Mol Biomarkers. 2011 Jul-Aug;15(7-8):569-72. doi: 10.1089/gtmb.2011.0008. Epub 2011 Mar 14.

Abstract

Background: The genetic basis of susceptibility to hepatocellular carcinoma (HCC) is poorly understood. Tumor necrosis factor alpha (TNF-α) is a cytokine that may act as an endogenous tumor promoter. The association between TNF-α 308 G/A polymorphism and HCC risk remains unclear.

Aim: The aim of this study was to investigate the association between TNF-α 308 G/A polymorphism and HCC risk in a Chinese population.

Methods: The study population consisted of 88 patients with documented HCC and 88 healthy controls. The gene polymorphism of TNF-α was analyzed by polymerase chain reaction-restriction fragment length polymorphism assay.

Results: HCC patients had a significantly lower frequency GG (odds ratio=0.36; 95% confidence interval=0.13, 0.94; p=0.04) and G allele (odds ratio=0.58; 95% confidence interval=0.37, 0.90; p=0.01) than healthy controls. When stratifying for tumor size and cirrhosis, no statistically significant results were found.

Conclusion: This study suggested that TNF-α -308GG and G allele were associated with a modest decrease in the risk of HCC in Chinese population.

MeSH terms

  • Aged
  • Asian People / genetics*
  • Carcinoma, Hepatocellular / genetics*
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Liver Neoplasms / genetics*
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Tumor Necrosis Factor-alpha / genetics*

Substances

  • Tumor Necrosis Factor-alpha